FFA
RPRX icon

Farther Finance Advisors’s Royalty Pharma RPRX Stock Holding History

Farther Finance Advisors’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$194K Buy
3,324
+77
+2% +$4.54K ﹤0.01% 2322
2026
Q2 		$182K Sell
3,247
-15
-0.5% -$781 ﹤0.01% 2309
2026
Q1 		$158K Buy
3,262
+1,147
+54% +$50.2K ﹤0.01% 2188
2025
Q4 		$81.7K Buy
2,115
+55
+3% +$2.1K ﹤0.01% 2471
2025
Q3 		$72.7K Buy
2,060
+632
+44% +$22.9K ﹤0.01% 2232
2025
Q2 		$51.5K Buy
1,428
+760
+114% +$25.2K ﹤0.01% 2120
2025
Q1 		$20.8K Buy
668
+31
+5% +$983 ﹤0.01% 2368
2024
Q4 		$16.3K Buy
637
+222
+53% +$5.89K ﹤0.01% 2172
2024
Q3 		$11.8K Sell
415
-30
-7% -$831 ﹤0.01% 2306
2024
Q2 		$11.7K Sell
445
-40
-8% -$1.11K ﹤0.01% 2018
2024
Q1 		$14.5K Sell
485
-39
-7% -$1.15K ﹤0.01% 1605
2023
Q4 		$14.7K Buy
524
+497
+1,841% +$13.7K ﹤0.01% 1441
2023
Q3 		$733 Buy
27
+14
+108% +$416 ﹤0.01% 2163
2023
Q2 		$400 Sell
13
-25
-66% -$847 ﹤0.01% 2215
2023
Q1 		$1.37K Buy
38
+33
+660% +$1.22K ﹤0.01% 1764
2022
Q4 		$198 Buy
+5
New +$209 ﹤0.01% 2041

Other funds holding RPRX

EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
KA
Kearns & Associates Palos Verdes Estates, California $218M AUM 16.36% 1-Year Est. Return
MGI
Miller Global Investments Dallas, Texas $124M AUM 25.7% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 31.62% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $271M AUM
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Farther Finance Advisors's RPRX Position: Q3 2026 in Review

Farther Finance Advisors increased its Royalty Pharma (RPRX) stake by 2.4% in Q3 2026, buying an estimated $4.54K and bringing the position to 3,324 shares worth $194K. The position accounts for ﹤0.01% of the portfolio, ranked #2322.

Farther Finance Advisors first reported a position in RPRX in Q4 2022 and has held it in 16 quarters since. 21 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Farther Finance Advisors held 3,324 shares of Royalty Pharma worth $194K as of Q3 2026.
  • Farther Finance Advisors bought 77 Royalty Pharma shares in Q3 2026, an estimated $4.54K.
  • Royalty Pharma made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #2322 holding.
  • Farther Finance Advisors first reported a position in Royalty Pharma in Q4 2022 and has held it in 16 quarters since.
  • 21 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.